T and NK cells in the spleen of vaccinated mice
. | Percent of splenocytes (SD) . | . | . | . | |||
|---|---|---|---|---|---|---|---|
| Vaccine . | CD3 . | CD4 . | CD8 . | NK . | |||
| DA1-3b/CXCL10 | 57 (7) | 21 (4) | 34 (6) | 38 (5) | |||
| DA1-3b/IL12 | 76 (8) | 28 (3) | 39 (5) | 29 (3) | |||
| DA1-3b/Zeo | 11 (2) | 5 (2) | 5 (2) | 24 (3) | |||
. | Percent of splenocytes (SD) . | . | . | . | |||
|---|---|---|---|---|---|---|---|
| Vaccine . | CD3 . | CD4 . | CD8 . | NK . | |||
| DA1-3b/CXCL10 | 57 (7) | 21 (4) | 34 (6) | 38 (5) | |||
| DA1-3b/IL12 | 76 (8) | 28 (3) | 39 (5) | 29 (3) | |||
| DA1-3b/Zeo | 11 (2) | 5 (2) | 5 (2) | 24 (3) | |||
Mice were vaccinated with irradiated DA1-3b cells transduced with vector containing IL-12 (DA1-3b/IL 12), CXCL10 (DA1-3b/CXCL10), or control empty vector (DA1-3b/Zeo), and spleen cells were analyzed by flow cytometry.